4//SEC Filing
Sandison Taylor 4
Accession 0001209191-22-002601
CIK 0001610618other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 8:22 PM ET
Size
9.9 KB
Accession
0001209191-22-002601
Insider Transaction Report
Form 4
Sandison Taylor
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-29+15,600→ 256,231 total - Exercise/Conversion
Restricted Stock Unit
2021-12-29−10,000→ 12,500 totalExp: 2027-09-17→ Common Stock (10,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2021-12-29−5,600→ 6,300 totalExp: 2029-01-30→ Common Stock (5,600 underlying)
Footnotes (5)
- [F1]The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
- [F2]Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021.
- [F3]Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
- [F4]On September 18, 2017, the Reporting Person was granted restricted stock units totaling 25,000 shares subject to vesting upon the achievement of various milestones.
- [F5]On January 31, 2019, the Reporting Person was granted restricted stock units totaling 14,000 shares subject to vesting upon the achievement of various milestones.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001702287
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 8:22 PM ET
- Size
- 9.9 KB